Compugen Ltd at Stifel Virtual Healthcare Conference Transcript
Good morning, everyone. I am Stephen Willey, one of the senior biotech analysts here at Stifel. I appreciate everyone's attendance at the 2020 virtual healthcare conference.
With us this morning from Compugen we have a number of senior executives participating in the discussion we're going to have today -- Anat Cohen-Dayag, who is the Chief Executive Officer; Ari Krashin, who is the CFO; Eran Ophir, who is the Chief Medical Officer and -- or Chief Scientific Officer, I'm sorry; and then Henry Adewoye, who just joined us is the Chief Medical Officer. So Anat, I don't know if you want to kind of make any opening statements before we get into Q&A just with respect to who you are, what you do.
Sure. We are a therapeutic discovery and development company. We discover new drug targets and new biological pathways and we develop first-in-class drugs in order to address these drug targets. And the way we discover new drug targets is by a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
